ARROWHEAD PHARMACEUTICALS INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in ARROWHEAD PHARMACEUTICALS INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$35.6M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity3 increased2 reduced1 exited
Full exits: Point72 Asset Management, L.P.
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| OAKTREE CAPITAL MANAGEMENT LP CIK 0000949509 | Hedge Fund | 9.15M | $11.0M | 30.8% | 0.2% | Reduced | $-2.3M | Q2 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 8.50M | $10.2M | 28.7% | 0.0% | Added | — | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 7.10M | $8.5M | 23.9% | 0.0% | Added | — | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 3.13M | $3.8M | 10.5% | 0.0% | Reduced | $-300K | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 1.80M | $2.1M | 6.0% | 0.0% | Added | +$1.0M | Q2 2026 |
Reduced
Hedge Fund
$11.0M· 30.8% of total· 0.2% port· 9.15M sh· $-2.3M QoQ· Q2 2026
Added
Hedge Fund
$10.2M· 28.7% of total· 0.0% port· 8.50M sh· — QoQ· Q2 2026
Added
Hedge Fund
$8.5M· 23.9% of total· 0.0% port· 7.10M sh· — QoQ· Q2 2026
Reduced
Hedge Fund
$3.8M· 10.5% of total· 0.0% port· 3.13M sh· $-300K QoQ· Q2 2026
Added
Hedge Fund
$2.1M· 6.0% of total· 0.0% port· 1.80M sh· +$1.0M QoQ· Q2 2026